Eisenmenger’s syndrome ACC/AHA guidelines for reproduction: Difference between revisions
Jump to navigation
Jump to search
/* Reproduction - Eisenmenger's Syndrome (DO NOT EDIT){{cite journal| author=Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA et al.| title=ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a ... |
|||
| (15 intermediate revisions by 3 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
'''Associate Editor-In-Chief:''' {{CZ}}, [[Priyamvada Singh|Priyamavada Singh, MMBS]] [[mailto: | '''Associate Editor-In-Chief:''' {{CZ}}, [[Priyamvada Singh|Priyamavada Singh, MMBS]] [[mailto:psingh13579@gmail.com]]'''Assistant Editor-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [[mailto:kfeeney@elon.edu]] | ||
==Overview== | ==Overview== | ||
==ACC / AHA Guidelines | ==2008 ACC/AHA Guidelines for the Management of Adults With Congenital Heart Disease (DO NOT EDIT)<ref name="pmid19038677">{{cite journal| author=Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA et al.| title=ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. | journal=J Am Coll Cardiol | year= 2008 | volume= 52 | issue= 23 | pages= e1-121 | pmid=19038677 | doi=10.1016/j.jacc.2008.10.001 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19038677 }} </ref> == | ||
{{ | === Reproduction - Eisenmenger's Syndrome (DO NOT EDIT)<ref name="pmid19038677">{{cite journal| author=Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA et al.| title=ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. | journal=J Am Coll Cardiol | year= 2008 | volume= 52 | issue= 23 | pages= e1-121 | pmid=19038677 | doi=10.1016/j.jacc.2008.10.001 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19038677 }} </ref> === | ||
==[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]= | {| class="wikitable" | ||
|- | |||
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Women with severe [[CHD]]-[[PAH]], especially those with Eisenmenger physiology, and their partners should be counseled about the absolute avoidance of [[pregnancy]] in view of the high risk of [[maternal death]], and they should be educated regarding safe and appropriate methods of [[contraception]]. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''2.''' Women with CHD-PAH who become pregnant should:<nowiki>"</nowiki> | |||
should | |||
|- | |||
a. Receive individualized counseling from cardiovascular | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''a.''' Receive individualized [[counseling]] from [[cardiovascular]] and [[obstetric]] caregivers collaborating in care and with expertise in management of CHD-PAH. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | ||
and obstetric caregivers collaborating in care | |- | ||
and with expertise in management of CHD-PAH. | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''b.''' Undergo the earliest possible [[pregnancy termination]] after such counseling. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | ||
(Level of Evidence: C) | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''3.''' Surgical sterilization carries some operative risk for women with CHD-PAH but is a safer option than pregnancy. In view of advances in minimally invasive techniques, the risks and benefits of sterilization modalities should be discussed with an obstetrician experienced in management of high-risk patients, as well as with a cardiac [[anesthesiologist]]. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | |||
|} | |||
{| class="wikitable" | |||
|- | |||
| colspan="1" style="text-align:center; background:LightCoral"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] | |||
= | |- | ||
1. Pregnancy in women with CHD-PAH, especially those | | bgcolor="LightCoral"|<nowiki>"</nowiki>'''1.''' Pregnancy in women with CHD-PAH, especially those with Eisenmenger physiology, is not recommended and should be absolutely avoided in view of the high risk of [[maternal mortality]]. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | ||
with Eisenmenger physiology, is not recommended and | |||
should be absolutely avoided in view of the high risk of | |||
maternal mortality. (Level of Evidence: B) | |||
2. The use of single-barrier contraception alone in women | |- | ||
with CHD-PAH is not recommended owing to the | | bgcolor="LightCoral"|<nowiki>"</nowiki>'''2.''' The use of single-[[barrier contraception]] alone in women with [[CHD]]-[[PAH]] is not recommended owing to the frequency of failure. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | ||
frequency of failure. (Level of Evidence: C) | |||
3. Estrogen-containing contraceptives should be avoided. | |- | ||
(Level of Evidence: C) | | bgcolor="LightCoral"|<nowiki>"</nowiki>'''3.''' [[Estrogen]]-containing [[contraceptives]] should be avoided.''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | ||
|} | |||
===[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIb]]= | {| class="wikitable" | ||
1. Pregnancy termination in the last 2 trimesters of | |- | ||
pregnancy poses a high risk to the mother. It may be | | colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIb]] | ||
reasonable, however, after the risks of termination are | |- | ||
balanced against the risks of continuation of the pregnancy. | | bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' [[Pregnancy termination]] in the last 2 [[trimesters]] of pregnancy poses a high risk to the mother. It may be reasonable, however, after the risks of termination are balanced against the risks of continuation of the pregnancy.''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | ||
(Level of Evidence: C) | |} | ||
==References== | ==References== | ||
Latest revision as of 17:08, 16 November 2012
|
Eisenmenger’s syndrome Microchapters |
|
Diagnosis |
|---|
|
Eisenmenger’s syndrome ACC/AHA Guidelines for Evaluation of Patients |
|
Treatment |
|
Eisenmenger’s syndrome ACC/AHA guidelines for reproduction On the Web |
|
American Roentgen Ray Society Images of Eisenmenger’s syndrome ACC/AHA guidelines for reproduction |
|
FDA on Eisenmenger’s syndrome ACC/AHA guidelines for reproduction |
|
CDC on Eisenmenger’s syndrome ACC/AHA guidelines for reproduction |
|
Eisenmenger’s syndrome ACC/AHA guidelines for reproduction in the news |
|
Blogs on Eisenmenger’s syndrome ACC/AHA guidelines for reproduction |
|
Risk calculators and risk factors for Eisenmenger’s syndrome ACC/AHA guidelines for reproduction |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2], Priyamavada Singh, MMBS [[3]]Assistant Editor-In-Chief: Kristin Feeney, B.S. [[4]]
Overview
2008 ACC/AHA Guidelines for the Management of Adults With Congenital Heart Disease (DO NOT EDIT)[1]
Reproduction - Eisenmenger's Syndrome (DO NOT EDIT)[1]
| Class I |
| "1. Women with severe CHD-PAH, especially those with Eisenmenger physiology, and their partners should be counseled about the absolute avoidance of pregnancy in view of the high risk of maternal death, and they should be educated regarding safe and appropriate methods of contraception. (Level of Evidence: B)" |
| "2. Women with CHD-PAH who become pregnant should:" |
| "a. Receive individualized counseling from cardiovascular and obstetric caregivers collaborating in care and with expertise in management of CHD-PAH. (Level of Evidence: C)" |
| "b. Undergo the earliest possible pregnancy termination after such counseling. (Level of Evidence: C)" |
| "3. Surgical sterilization carries some operative risk for women with CHD-PAH but is a safer option than pregnancy. In view of advances in minimally invasive techniques, the risks and benefits of sterilization modalities should be discussed with an obstetrician experienced in management of high-risk patients, as well as with a cardiac anesthesiologist. (Level of Evidence: C)" |
| Class III |
| "1. Pregnancy in women with CHD-PAH, especially those with Eisenmenger physiology, is not recommended and should be absolutely avoided in view of the high risk of maternal mortality. (Level of Evidence: B)" |
| "2. The use of single-barrier contraception alone in women with CHD-PAH is not recommended owing to the frequency of failure. (Level of Evidence: C)" |
| "3. Estrogen-containing contraceptives should be avoided.(Level of Evidence: C)" |
| Class IIb |
| "1. Pregnancy termination in the last 2 trimesters of pregnancy poses a high risk to the mother. It may be reasonable, however, after the risks of termination are balanced against the risks of continuation of the pregnancy.(Level of Evidence: C)" |
References
- ↑ 1.0 1.1 Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA; et al. (2008). "ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (23): e1–121. doi:10.1016/j.jacc.2008.10.001. PMID 19038677.